Company: ANIX
Filing Date: 2025-02-06
Form Type: DEF 14A
Source: 0001493152-25-005199
Chunk: 5

Company: Anixa Biosciences Inc
Filing Date: 2025-02-06
Form: DEF 14A
Chunk 5
---
: This Proxy Statement, along with our Annual Report on Form 10-K for the year ended October 31, 2024, is available at: http://www.anixa.com/.

<div align='center'>TABLE OF CONTENTS</div>

|                                                                                                                                                                 | Page |
| QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS                                                                                                               |    1 |
| THE ANNUAL MEETING                                                                                                                                              |    6 |
| PROPOSAL 1 – ELECTION OF DIRECTORS                                                                                                                              |    9 |
| PROPOSAL 2 – APPROVAL ON A NON-BINDING, ADVISORY BASIS OF THE COMPENSATION OF NAMED EXECUTIVE OFFICERS                                                          |   25 |
| PROPOSAL 3 – RATIFICATION OF THE APPOINTMENT OF THE COMPANY’S INDEPENDENT AUDITORS FOR FISCAL 2025                                                              |   26 |
| PROPOSAL 4 – APPROVAL ON A NON-BINDING, ADVISORY BASIS OF THE FREQUENCY OF CONDUCTING FUTURE STOCKHOLDER ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION |   27 |
| OTHER INFORMATION                                                                                                                                               |   28 |

<div align='center'>PROXY STATEMENT

Anixa Biosciences, Inc.

ANNUAL MEETING OF STOCKHOLDERS

to be held virtually at 10:00 a.m. Pacific time on Thursday, March 20, 2025

QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS</div>

Why am I receiving this Proxy Statement?

The Company has made these materials available to you on the Internet or, upon your request, has delivered printed versions of these materials to you by mail, in connection with the Company’s solicitation of proxies for use at the 2025 Annual Meeting of Stockholders of the Company (the “ Virtual Meeting”) to be held on a virtual basis on Thursday, March 20, 2025 at 10:00 a.m. Pacific time, and at any postponement(s) or adjournment(s) thereof. These materials were first sent or given to stockholders on or about February 6, 2025. This proxy statement gives you information on these proposals so that you can make an informed decision.

In this proxy statement, we refer to Anixa Biosciences, Inc. as the “Company”, “we”, “us” or “our” or similar terminology.

What is included in these materials?

These materials